Genprex, Inc.

( )
GNPX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. 0.06%34.050.9%$1164.32m
JNJJohnson & Johnson 0.00%142.810.7%$1084.56m
BMYBristol-Myers Squibb Co. 0.78%60.771.0%$992.91m
MRKMerck & Co., Inc. 0.10%78.780.7%$831.79m
ABBVAbbVie, Inc. -0.42%99.001.9%$784.99m
LLYEli Lilly & Co. -0.09%166.741.1%$696.31m
VXRTVaxart, Inc. 5.86%9.390.0%$317.61m
AZNAstraZeneca Plc 0.73%53.871.2%$297.34m
RPRXRoyalty Pharma Plc 2.04%47.050.1%$233.45m
NVSNovartis AG 0.02%87.820.2%$155.54m
GSKGlaxoSmithKline Plc 0.92%40.740.2%$118.47m
RGENRepligen Corp. -1.94%124.147.1%$117.72m
NVONovo Nordisk A/S 0.58%65.440.1%$95.02m
RETAReata Pharmaceuticals, Inc. -2.99%155.643.4%$81.74m
SNYSanofi 0.66%51.770.2%$74.29m

Company Profile

Genprex, Inc. is a clinical stage gene therapy company, which engages in the development of novel proprietary technology platform for the treatment of cancer. It develops the Oncoprex immunogene therapy which targets the non-small cell lung cancer and other solid tumors. The company was founded by J. Rodney Varner in April 2009 and is headquartered in Austin, TX.